Business
Warren Buffett’s $7.8b pharma bet – The Australian Financial Review
The investment in drugmakers by “the Oracle of Omaha” will be closely scrutinised by Wall Street.
The four new purchases more than doubled the size of Berkshires investments in healthcare stocks in the third quarter to $US9.3 billion in total. The company already held stakes in the drugmakers Biogen, Johnson & Johnson and Teva Pharmaceuticals and DaVita, a kidney dialysis company.
Mr Buffett did not respond to a request for comment.
Berkshire cut its stake in several large banks during the three months to the end of September, including Wells Fargo, JPMorgan Chase, PNC Financial and M&T Bank….
-
Business21 hours agoBrokers name 3 quality ASX 200 shares to buy today
-
Noosa News17 hours agoFirst home buyers’ options to almost double under expanded Home Guarantee Scheme
-
Noosa News18 hours agoSun Spirit sculpture returns ahead of Swell Sculpture Festival
-
Business19 hours agoMorgans says these ASX shares could rise 30%+